132 related articles for article (PubMed ID: 32550867)
1. A large-cohort retrospective study of metastatic patterns and prognostic outcomes between inflammatory and non-inflammatory breast cancer.
Wang Z; Wang H; Ding X; Chen X; Shen K
Ther Adv Med Oncol; 2020; 12():1758835920932674. PubMed ID: 32550867
[TBL] [Abstract][Full Text] [Related]
2. Racial and survival disparities in inflammatory breast cancer (IBC) and non-IBC: a population-based study focused on Native Hawaiians and other Pacific Islanders.
Yoshikawa GT; Miyazaki KS; Acoba JD; Fujii T
Front Oncol; 2024; 14():1390080. PubMed ID: 38826792
[TBL] [Abstract][Full Text] [Related]
3. Clinical Characteristics and Prognostic Factors of Endometrial Cancer Patients With Liver Metastasis: A Surveillance, Epidemiology, and End Results Database (SEER)-Based Study of 1,034 Women.
Alhadeethi A; Ibrahim AA; Atia A; Alabdallat YJ; Alkhawaldeh IM; El Din Moawad MH
Cureus; 2024 Feb; 16(2):e54606. PubMed ID: 38524022
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory and non-inflammatory breast cancer survival by socioeconomic position in the Surveillance, Epidemiology, and End Results database, 1990-2008.
Schlichting JA; Soliman AS; Schairer C; Schottenfeld D; Merajver SD
Breast Cancer Res Treat; 2012 Aug; 134(3):1257-68. PubMed ID: 22733221
[TBL] [Abstract][Full Text] [Related]
5. Clinicogenomic characterization of inflammatory breast cancer.
Priedigkeit N; Harrison B; Shue R; Hughes M; Li Y; Kirkner GJ; Spurr LF; Remolano MC; Strauss S; Files J; Feeney AM; Grant L; Mohammed-Abreu A; Garrido-Castro A; Sousa RB; Bychkovsky B; Nakhlis F; Bellon JR; King TA; Winer EP; Lindeman N; Johnson BE; Sholl L; Dillon D; Overmoyer B; Tolaney SM; Cherniack A; Lin NU; Lynce F
bioRxiv; 2024 May; ():. PubMed ID: 38766070
[TBL] [Abstract][Full Text] [Related]
6. Age-Dependent Heterogeneity of Lymph Node Metastases and Survival Identified by Analysis of a National Breast Cancer Registry.
Behring M; Bajpai P; Afaq F; Elkholy A; Kim HG; Al Diffalha S; Shrestha S; Manne U
J Pharm Pharmacol Res; 2022; 6(3):147-157. PubMed ID: 36304424
[TBL] [Abstract][Full Text] [Related]
7. Mining and validation of prognosis of various visceral metastasis in renal cell carcinoma: a study based on SEER database.
Liu Y; Cheng W; Yang Q; Han Y; Jiang Q; Yang Y; Zhang H
Updates Surg; 2024 Apr; 76(2):657-676. PubMed ID: 38165526
[TBL] [Abstract][Full Text] [Related]
8. Metastatic pattern and prognosis in patients with lung adenosquamous carcinoma: A surveillance, epidemiology, and end results-based population study.
Xie J; Li C
Heliyon; 2024 May; 10(9):e30641. PubMed ID: 38765098
[TBL] [Abstract][Full Text] [Related]
9. Patterns of distant metastasis and survival outcomes in
Liu K; Huang AL; Chen XQ; Wu SG
Front Endocrinol (Lausanne); 2024; 15():1385756. PubMed ID: 38752173
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non-inflammatory breast cancer.
Schairer C; Brown LM; Mai PL
Breast Cancer Res Treat; 2011 Aug; 129(1):117-24. PubMed ID: 21390499
[TBL] [Abstract][Full Text] [Related]
11. Distant organ metastasis patterns and prognosis of cervical adenocarcinoma: a population-based retrospective study.
Li S; Pan W; Song J; Zhen L; Chen Y; Liu W; Zhang Y; Chen L; Huang Q; Zheng S; Zheng X
Front Med (Lausanne); 2024; 11():1401700. PubMed ID: 38873215
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and tumour microenvironment characteristics of the Glasgow Microenvironment Score in primary triple-negative breast cancer.
Lu X; Wang Y; He M; Gou Z
J Clin Pathol; 2024 Jan; 77(2):128-134. PubMed ID: 36600565
[TBL] [Abstract][Full Text] [Related]
13. Overall Survival and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A National Cancer Database Analysis.
Kesireddy M; Elsayed L; Shostrom VK; Agarwal P; Asif S; Yellala A; Krishnamurthy J
Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791870
[TBL] [Abstract][Full Text] [Related]
14. Failure patterns and survival outcomes in triple negative breast cancer (TNBC): a 15 year comparison of 448 non-Hispanic black and white women.
Prasad S; Efird JT; James SE; Walker PR; Zagar TM; Biswas T
Springerplus; 2016; 5(1):756. PubMed ID: 27386241
[TBL] [Abstract][Full Text] [Related]
15. Increased risk of multiple metastases and worse overall survival of metastatic pancreatic body and tail cancer: a retrospective cohort study.
Zhang H; Tan Q; Xiang C; Liu X; Zheng Z
Gland Surg; 2024 Apr; 13(4):480-489. PubMed ID: 38720678
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer.
Xiao W; Li X; Yang A; Chen B; Zheng S; Zhang G; Deng W; Liao N
Front Oncol; 2020; 10():431. PubMed ID: 32309214
[TBL] [Abstract][Full Text] [Related]
17. Homeoprotein DLX4 expression is increased in inflammatory breast cancer cases from an urban African-American population.
Jeong J; Naab TJ; Fernandez AI; Ongkeko MS; Makambi KH; Blancato JK
Oncotarget; 2018 Jul; 9(58):31253-31263. PubMed ID: 30131852
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory breast cancer: Epidemiologic data and therapeutic results.
Boussen H; Berrazaga Y; Sherif Kullab ; Manai M; Berrada N; Mejri N; Siala I; Levine PH; Cristofanilli M
Int Rev Cell Mol Biol; 2024; 384():1-23. PubMed ID: 38637094
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Factors Affecting Survival of Patients With Single Primary Breast Cancer vs Patients With Multiple Primary Cancers in Lifetime, One of Which is Breast Cancer.
Sanli AN; Tekcan Sanli DE; Altundag MK; Aydogan F
Am Surg; 2024 Apr; ():31348241248695. PubMed ID: 38676386
[TBL] [Abstract][Full Text] [Related]
20. Dural Metastasis in Breast Cancer: MRI-Based Morphological Subtypes and Their Clinical Implications.
Ahn SJ; Joo B; Park M; Park HH; Suh SH; Ahn SG; Yoo J
Cancer Res Treat; 2024 Mar; ():. PubMed ID: 38514195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
